Lorenz Kevin 4
4 · Fortress Biotech, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Lorenz Kevin
Director
Transactions
- Purchase
COMMON STOCK, PAR VALUE $0.001
2020-01-01+50,000→ 164,582 total
Footnotes (2)
- [F1]One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service.
- [F2]Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019.